Table of Contents
To view the fulltext, log-in or choose pay-per-view options:
Get Access

Eosinophil Development and Bone Marrow and Tissue Eosinophils in Atopic Asthma

Robinson D.S.a · North J.a · Zeibecoglou K.a · Ying S.a · Meng Q.a · Rankin S.b · Hamid Q.c · Tavernier J.d · Kay A.B.a
aAllergy and Clinical Immunology and bLeukocyte Biology, Imperial College School of Medicine, National Heart and Lung Institute, London, UK; cMeakins Christie Laboratories, McGill University, Montreal, Canada; dDepartment of Medical Protein Chemistry, Flanders Inter–University Institute for Biotechnology, Gent, Belgium Int Arch Allergy Immunol 1999;118:98–100 (DOI:10.1159/000024039)

Abstract

Background: Eosinophils develop from bone marrow (BM) progenitors, and interleukin–5 (IL–5) and eotaxin may act in expansion and mobilisation of BM eosinophils in asthma. Methods: We have examined phenotypic changes as CD34+ cells develop to the eosinophil lineage in vitro, and have evaluated BM eosinophils from asthmatic and control subjects for expression of the eotaxin receptor, CCR3. Results: Acquisition of receptors for IL–5 and CCR3 was an early event in eosinophil development. There were increased CD34+ cells, and mature and immature CCR3+ eosinophils in BM from asthmatics. Conclusion: These data suggest that IL–5 may act early in eosinophil development, and that eotaxin has the capacity to mobilise a BM eosinophil pool in asthma.

 

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00